Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT01847209
This is a phase II protocol to determine the safety and feasibility of Intraoperative CT fluoroscopy guidance for lung resection for small nodules.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Boston, Massachusetts, 02115, United States
This is a phase II protocol to determine the safety and feasibility of image guided CT marking for resection of small lung nodules. This is relevant because many such nodules are hard to localize for minimally invasive lung resection. It is hoped that this technology using fluoro CT capability available now in most operating room will improve safety and reliability of thoracic surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Nodules marked with fiducials such as Kopan needles under CT fluoroscopy followed by VATS wedge resection.
Time frame: 30 days
The patient will be monitored while in the hospital by their thoracic surgical team as well as by two research nurses named Lauren Donahue, RN and Karen Magsipoc, NP. The research nurses will document any perioperative complications and mortality that arise during the patient's stay in the hospital.
Time frame: 30 days
Number of patients who underwent a successful resection which is measured by an accurate and appropriate resection in a given timeline
Brigham and Women's Hospital
Other
Percutaneous Image Guided Video Assisted Thoracic Surgery (VATS) Resection of Lung Lesions
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00340405
Lung Cancer, Lung Diseases
Beijing, China
View Trial DetailsNCT03117946
Head and Neck Cancer, Head and Neck Neoplasms
Besançon, France
View Trial DetailsNCT05832008
Adherence, Patient, Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06084208
Lung Cancer, Lung Diseases
Nijmegen, Netherlands
View Trial Details